Park Avenue Securities’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,028
| Closed | -$123K | – | 1301 |
|
|
2024
Q4 | $123K | Buy |
+13,028
| New | +$123K | ﹤0.01% | 1449 |
|
|
2024
Q3 | – | Sell |
-14,513
| Closed | -$144K | – | 1407 |
|
|
2024
Q2 | $144K | Buy |
14,513
+1,355
| +10% | +$13.4K | ﹤0.01% | 1331 |
|
|
2024
Q1 | $155K | Buy |
13,158
+673
| +5% | +$7.93K | ﹤0.01% | 1335 |
|
|
2023
Q4 | $177K | Buy |
12,485
+1,961
| +19% | +$27.8K | ﹤0.01% | 1307 |
|
|
2023
Q3 | $128K | Buy |
+10,524
| New | +$128K | ﹤0.01% | 1237 |
|
|
2023
Q1 | – | Sell |
-10,527
| Closed | -$129K | – | 869 |
|
|
2022
Q4 | $129K | Buy |
+10,527
| New | +$129K | ﹤0.01% | 1165 |
|